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1Despite the beneficial effects of percutaneous transluminal coronary angioplasty and stent implantation, these pro-
cedures may damage the vessel wall, particularly the endo-
thelial layer, leading to increased vascular permeability and 
remodeling. Therefore, noninvasive assessment of these pro-
cesses may provide a more comprehensive understanding of 
the focal responses of the vessel wall to injury.
See Clinical Perspective
In healthy vessels, functional endothelium produces nitric 
oxide through endothelial nitric oxide synthase (eNOS or 
NOS3). Nitric oxide controls the vasoreactivity of the ves-
sel wall, inhibits platelet and leukocyte adhesion and smooth 
muscle cell proliferation and migration, promotes re-endothe-
lialization, and regulates endothelial cell and tight junction 
morphology and vascular permeability.1,2 Dysfunctional endo-
thelium because of vascular injury or cardiovascular risk fac-
tors3–7 is characterized by reduced NOS3-derived nitric oxide 
resulting in the attenuation of endothelial-dependent vasodila-
tion5,8 and accelerated vascular remodeling.9–12
Genetically modified NOS3−/− mice (1) vasodilate only 
in response to endothelial-independent stressors,13 (2) have 
Background—Despite the beneficial effects of vascular interventions, these procedures may damage the endothelium 
leading to increased vascular permeability and remodeling. Re-endothelialization of the vessel wall, with functionally 
and structurally intact cells, is controlled by endothelial nitric oxide synthase (NOS3) and is crucial for attenuating 
adverse effects after injury. We investigated the applicability of the albumin-binding MR contrast agent, gadofosveset, to 
noninvasively monitor focal changes in vascular permeability and remodeling, after injury, in NOS3-knockout (NOS3−/−) 
and wild-type (WT) mice in vivo.
Methods and Results—WT and NOS3−/− mice were imaged at 7, 15, and 30 days after aortic denudation or sham-surgery. 
T1 mapping (R1=1/T1, s−1) and delayed-enhanced MRI were used as measurements of vascular permeability (R1) and 
remodeling (vessel wall enhancement, mm2) after gadofosveset injection, respectively. Denudation resulted in higher 
vascular permeability and vessel wall enhancement 7 days after injury in both strains compared with sham-operated 
animals. However, impaired re-endothelialization and increased neovascularization in NOS3−/− mice resulted in 
significantly higher R1 at 15 and 30 days post injury compared with WT mice that showed re-endothelialization and lack 
of neovascularization (R1 [s−1]=15 days: NOS3−/−4.02 [interquartile range, IQR, 3.77–4.41] versus WT2.39 [IQR, 2.35–2.92]; 
30 days: NOS3−/−4.23 [IQR, 3.94–4.68] versus WT2.64 [IQR, 2.33–2.80]). Similarly, vessel wall enhancement was higher in 
NOS3−/− but recovered in WT mice (area [mm2]=15 days: NOS3−/−5.20 [IQR, 4.68–6.80] versus WT2.13 [IQR, 0.97–3.31]; 
30 days: NOS3−/−7.35 [IQR, 5.66–8.61] versus WT1.60 [IQR, 1.40–3.18]). Ex vivo histological studies corroborated the MRI 
findings.
Conclusions—We demonstrate that increased vascular permeability and remodeling, after injury, can be assessed noninvasively 
using an albumin-binding MR contrast agent and may be used as surrogate markers for evaluating the healing response of 
the vessel wall after injury.  (Circ Cardiovasc Imaging. 2015;8:e002417. DOI: 10.1161/CIRCIMAGING.114.002417.)
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impaired re-endothelialization,12,14,15 and (3) have increased 
inflammatory response after injury12,16 collectively leading to 
increased vascular remodeling.10–12 However, despite some 
of the similarities between the vascular response observed in 
NOS3−/− and patients that undergo percutaneous interventions, 
endothelial denudation followed by vascular remodeling, as 
seen in this model, may represent the worst case outcome 
compared with human interventions. Interestingly, in a rabbit 
model, viral and nonviral transfection of NOS3 and placement 
of NOS3 gene–eluting stents significantly reduced vascular 
remodeling and improved re-endothelialization.14,15,17
Uptake into the vessel wall of albumin-binding dyes (Evans 
blue, 128I-albumin, rhodamine) has been traditionally used as 
a surrogate marker of vascular permeability in ex vivo experi-
ments.18 MRI is a noninvasive modality that allows the study 
of both endothelial function19–21 and vascular remodeling with 
high spatial resolution.22–25 An albumin-binding MRI contrast 
agent, gadofosveset, has been recently used as the in vivo coun-
terpart of albumin-binding dyes and allowed the assessment of 
focal changes in vascular permeability and vascular remodel-
ing in atherosclerosis,25–28 stent-induced vascular remodeling,27 
and chronic myocardial infarction.29 Gadofosveset is a clini-
cally approved gadolinium-based, blood pool contrast agent. 
After injection in mice, ≈70% of circulating gadofosveset binds 
reversibly to serum albumin and this increases its r1 relaxivity 
by 5- to 10-fold (r1=25 mmol L−1 s−1) compared with the free 
fraction (r1=5 mmol L−1 s−1).30,31 Uptake of gadofosveset into 
the vessel wall of pathological tissues has been shown to occur 
through damaged endothelium32,33 and leaky neovessels.26,27
Endothelial damage and vascular remodeling may occur 
after vascular injury. Re-endothelialization of the vessel wall 
with functionally and structurally intact endothelial cells is 
crucial for minimizing vascular remodeling and maintaining 
the long-term patency of the treated vessel. We hypothesized 
that augmented vascular permeability because of impaired re-
endothelialization and increased neovascularization, observed 
after injury in the NOS3−/− mice,12 is associated with enlarged 
vascular remodeling that could be monitored noninvasively 
using gadofosveset-enhanced MRI in vivo.
Methods
Animals/Endothelial Denudation
Wild-type (WT) C57BL/6 mice and B6.129P2-Nos3tm1Unc/J knock-out 
mice (8–12 weeks old) were purchased from the Jackson Laboratory 
(Bar Harbor, ME). Surgery was performed under isoflurane anesthe-
sia using a dissection microscope (Leica, Wetzar, Germany). Before 
surgery, the abdominal fur was removed with lotion hair and the 
surgical field was disinfected. After a midline incision of the abdo-
men, the aorta, renal, and iliac arteries were exposed and isolated. 
Subsequently, 2 ligatures (surgical silk, size 4-0, Aragó, Zaragoza, 
Spain) were placed around the aorta, below the renal arteries, and 
above the iliac bifurcation, respectively (Figure 1A; left). A 30G sy-
ringe was introduced into the abdominal aorta via an aortic puncture 
followed by a bolus infusion of 1-mL saline buffer. This procedure 
was repeated 3× to remove the endothelial cells (Figure 1A; right). 
Finally, the needle was removed, the aortic puncture was repaired, 
and the ligatures were removed to restore blood flow. The muscle and 
skin incisions were sutured (5-0 Vicryl, Ethicon Inc, Somerville, NJ), 
and the animals were allowed to recover. Each surgery lasted 30 min-
utes. Sham-operated animals underwent the same surgical procedure 
described above without injuring the endothelial layer. All procedures 
used in these studies were performed in accordance with the guide-
lines of the UK Home Office.
In Vivo MRI Protocol at 3T
In vivo vessel wall imaging was performed using a Philips Achieva 
MR scanner (Philips Healthcare, Best, The Netherlands) equipped 
Figure 1. Endothelial denudation model.  
A (left), Isolation and temporal obstruc-
tion of blood flow in the abdominal aorta 
between renal arteries and iliac bifurcation. 
A (right), Infusion of saline solution (0.9% 
NaCl) with a 30G syringe to denudate vas-
cular endothelial cells. B, In situ Evans blue 
dye staining shows increased vessel per-
meability in animals 1 hour after injury when 
compared with sham-operated mice (n=4). 
C, Hematoxylin and eosin staining showing 
the presence of endothelial cells in sham-
operated animals (left) and the absence of 
endothelial cells 1 hour after injury (right) 
in wild-type (WT) animals (n=3). D, Cor-
responding immunohistochemistry for 
PECAM-1 shows a significant decrease of 
endothelial cells in injured compared with 
sham-operated animals (n=3). E, Scale 
bars correspond to 0.3 mm.
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with a clinical gradient system (30 mT m−1, 200 mT m−1 ms−1) and a 
single-loop surface coil (diameter=47 mm). Mice were imaged before, 
7, 15, and 30 days after the surgery (Figure I in the Data Supplement). 
Four sham-operated mice and 6 injured mice per strain were imaged 
per time point. Animals were imaged in supine position before and 30 
minutes after intravenous administration of 0.03 mmol/kg gadofosve-
set (Lantheus Medical Imaging, North Billerica, MA). Anesthesia was 
induced with 5% and maintained with 1% to 2% isoflurane during 
the MRI experiments. After 3-dimensional (3D) gradient echo scout 
scans, contrast-enhanced angiography images were acquired for vi-
sualization of the vasculature with a field of view (FOV)=35×35×16 
mm, matrix=232×233, in-plane resolution=0.15×0.15 mm, slice thick-
ness=0.5 mm, repetition time/echo time (TR/TE)=28/6 ms, and flip 
angle=40°. The maximum intensity projection images were used to plan 
the subsequent delayed enhancement (DE) and T1 mapping scans. A 
2D-Look–Locker sequence planned perpendicular to the aorta was used 
to determine the optimal inversion time (TI) for blood signal nulling. 
Acquisition parameters were FOV=30×30 mm, matrix=76×75, in-plane 
resolution=0.4×0.4 mm, slice thickness=2 mm, TR/TE=18/8.3 ms, TR 
between subsequent IR pulses=1000 ms, and flip angle=10°. An inver-
sion-recovery 3D fast gradient echo sequence was acquired 30 minutes 
post injection and was used for DE-MRI and visualization of contrast up-
take. Imaging parameters were FOV=35×35×12 mm, matrix=348×348, 
in-plane resolution=0.1×0.1×1 mm (normal vessel wall thickness=0.2 
mm), slices=24, TR/TE=27/8.2 ms, TR between subsequent infrared 
pulses=1000 ms, and flip angle=30°. T1 mapping was performed using 
a sequence that uses 2 nonselective inversion pulses each followed by 
8-segmented readouts. The 2 imaging trains result in a set of 16 images 
per slice with increasing inversion times ranging from 20 to 2000 ms. 
For T1 mapping, the acquisition parameters were FOV=36×22×10 mm, 
matrix=180×102, in-plane resolution=0.2×0.21×0.5 mm, slices=20, 
TR/TE=9/4.6 ms, and flip angle=10°. R1 values were computed on a 
pixel-by-pixel basis using in house Matlab software.24
MRI Data Analysis
Vascular remodeling was calculated by manually segmenting the vi-
sually contrast-enhanced area of the vessel wall as seen on the DE-
MRI images using OsiriX (OsiriX Foundation, Geneva, Switzerland). 
To ensure that the segmented area encompassed the vessel wall, the 
DE-MRI images were coregistered and fused with the magnetic reso-
nance angiographic images. DE-MRI areas were measured on con-
secutive slices along the aorta and were added for each animal to 
express the total extent of vessel wall remodeling. R1 values were 
measured on consecutive slices along the aorta and were averaged 
for each animal.
Histology
Tissue Harvesting
For all histological procedures, mice were anesthetized with 
isoflurane and perfused through the left ventricle with physi-
ological saline (for transmission electron microscopic [TEM] 
studies and Evans blue dye [EBD] staining) or with physiolog-
ical saline followed by 10% buffered formalin (for hematoxy-
lin and eosin [H&E] staining and immunohistochemistry).
EBD Staining
Vascular permeability was assessed by visualizing and quanti-
fying the leakage of EBD into the vessel wall. Mice were anes-
thetized, and EBD (0.1 mL of 1% dye in saline) was injected 
in the left ventricle. After 10 minutes, the injured abdominal 
aorta was isolated, dried, and weighed. EBD was extracted by 
incubation in formamide for 24 hours at 60°C and the absor-
bance was measured at 620 nm. Standard curves for pure EBD 
were used to calculate the total amount of dye in the tissue. 
Four animals were analyzed per group at each time point.
H&E staining and immunohistochemistry
Abdominal aortas were fixed in 10% buffered formalin for 48 
hours at 4ºC, embedded in paraffin, and sectioned transversely 
(5-μm thick). H&E staining was used to investigate vessel wall 
morphology. Immunohistochemistry using antibodies to plate-
let endothelial cell adhesion (PECAM-1; 1:50, BD Pharmin-
gen, Oxford, UK) and serum albumin (1:5000, Abcam, 
Cambridge, UK) was used to study endothelial cells and serum 
albumin present in the vessel wall, respectively. Five slices (5 
μm) were stained per animal. Digital images were used to ana-
lyze the histological sections using ImageJ (NIH).
Vascular remodeling was used to describe 2 changes that 
occur in the vessel wall after injury: neointima formation that 
involves the inward deposition of cellular components and 
extracellular matrix proteins at the luminal surface, and the 
accumulation of extracellular matrix/collagen and neovessels 
at the periphery of the adventitial contour of the vessel wall. 
Vascular remodeling was calculated using the H&E images 
[adventitia area−the luminal area (mm2)]. Immunopositive 
areas were analyzed on digital images by computerized pla-
nimetry. The immunopositive area was segmented on the 
images and expressed as normalized albumin area (%; albu-
min immunopositive area/area of vascular remodeling)×100. 
Individual measurements performed within each animal were 
averaged and 4 animals were analyzed per group at each time 
point.
Transmission Electron Microscopy
Preselected segments of the aorta that showed enhancement 
on MRI (n=1 per time point per group) were pinned down and 
fixed in 2% glutaraldehyde in 0.1 mol/L sodium phosphate 
buffer (pH 7.4) for 2 hours, washed with sodium phosphate 
buffer for 2 hours, and post fixed in 1% OsO4 for 2 hours. 
Each aorta was divided into 3 levels (upper, middle, and low) 
starting from the left renal branch to the iliac bifurcation and 
processed for histological analysis. Subsequently, 3 sections 
were examined from the aorta of each animal. Samples were 
dehydrated through a graded series of ethanol and embed-
ded in epoxy resin. Semithin sections (0.2 μm) were stained 
with toluidine blue for light microscopy examinations and 
were used to guide sampling for TEM studies. Thin sections 
(0.09 μm) were collected on 150 mesh copper grids and dou-
ble stained with uranyl acetate and lead citrate for electron 
microscopy examinations (H7650, Hitachi, Tokyo, Japan).
Statistical Analysis
GraphPad Prism 5.00 was used for the statistical analysis. 
Two-group comparisons of continuous variables were per-
formed with a Mann–Whitney nonparametric exact test after 
the variables were ranked. The data are presented as the 
median±interquartile range, and P values <0.05 were used to 
define statistical significance.
Results
Endothelial Denudation Protocol
Histological validation and characterization of the surgical 
protocol was shown in our previous work, where we show that 
this procedure removes virtually all endothelial cells over the 
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area being subjected to the saline infusion procedure.12 Rep-
resentative images of the surgical protocol are illustrated in 
Figure 1A. EBD staining, a histological marker of endothelial 
permeability, was performed in a subgroup of WT animals, 
showing endothelial denudation 1 hour after surgery. En face 
photographs of the extracted aortas showed increased uptake 
of EBD demonstrating higher vascular permeability in injured 
animals compared with the sham-operated mice (Figure 1B). 
H&E staining and PECAM-1 immunohistochemistry further 
demonstrate that the endothelium was successfully removed 
after vascular injury compared with sham-operated animals 
(Figure 1C and 1D).
MRI Findings
Vascular permeability was measured using relaxation rate (R1) 
maps that allow in situ quantification of the gadolinium con-
centration in the vessel wall (Figure 2). This analysis revealed 
significantly higher R1 in denudated animals, in both strains, 7 
days after injury compared with sham-operated mice. Impor-
tantly, NOS3−/− mice showed significantly higher R1 15 and 30 
days after injury compared with WT mice that show restora-
tion of the R1 values close to baseline (Figure 2; graph). These 
results suggest healing of the vessel wall and normalization of 
vascular permeability in WT whereas in NOS3−/− mice vascu-
lar permeability remained increased after injury.
Vascular remodeling was quantified using DE-MR images 
after administration of gadofosveset. Similar to the R1 values, 
DE-MRI areas were higher in the abdominal aorta of both 
WT and NOS3−/− mice 7 days after injury compared with 
sham-operated animals (Figure 3, second row). Importantly, 
in NOS3−/− mice, the area of vessel wall enhancement 
remained higher 15 and 30 days after injury compared with 
that observed in WT mice at the same time points (Figure 3, 
third and fourth rows). The area of vessel wall enhancement 
in WT mice 15 and 30 days post injury was similar to that 
observed in sham-operated animals (Figure 3, first column). 
The quantitative changes in the DE-MRI area are also illus-
trated (Figure 3; graph). Finally, correlation analysis showed 
a strong linear correlation between DE-MRI and R1 (r=0.702; 
P<0.001; Figure IIA in the Data Supplement). Collectively, 
these data suggest that the differential response in vascular 
permeability and remodeling, after injury, between NOS3−/− 
and WT can be assessed noninvasively by R1 mapping and 
DE-MRI after gadofosveset administration.
Histological Findings
Ex vivo histological analysis corroborated the in vivo MRI 
data. EBD (Figure 4A) and albumin immunohistochemistry 
(Figure 4B) showed that at 7 days after injury both NOS3−/− 
and WT had focal uptake of the dye and albumin immunopos-
itive areas indicating uptake of the EBD and albumin into 
the vessel wall because of increased vascular permeability. 
However, NOS3−/− showed persistent and significantly higher 
uptake of EBD and albumin in the injured segment of the 
abdominal aorta at 15 and 30 days post injury compared with 
WT mice. Vessels from sham-operated mice, of both strains, 
showed low uptake of EBD and albumin immunopositive 
areas located primarily in the adventitial layer and to a lesser 
extent in the endothelium.
PECAM-1 immunohistochemistry showed impaired re-
endothelialization in NOS3−/− compared with WT mice after 
injury (Figure 5A). Furthermore, PECAM-1 immunohisto-
chemistry revealed neovessel formation within the remod-
eled area (Figure 5B), breaks in-between adjacent endothelial 
cells (Figure 5C), and regions of denudation (Figure 5D) in 
NOS3−/− mice but not in WT mice, which showed complete 
re-endothelialization 30 days after surgery (Figure 5E). H&E 
staining showed increased vascular remodeling in NOS3−/− 
compared with WT mice after injury (Figure 5F). Quantitative 
differences in vessel wall area between the 2 mice strains were 
significant at 7, 15, and 30 days post injury (Figure 5F; graph).
Qualitative ultrastructural changes after vessel wall injury 
were studied with TEM (Figure III in the Data Supplement). 
At 7 days post injury, the endothelial layer was absent in 
both strains. In WT mice, the vessel wall was re-endotheli-
alized with endothelial cells that appeared elongated and had 
cytoplasmic vacuolization and microvilli at 15 and 30 days. 
Conversely, NOS3−/− mice showed re-endothelialization with 
cuboidal endothelial cells and partial fragmentation of elastin 
fibers.
Correlation analysis between the MRI measurements and 
histology showed a strong linear correlation between the vessel 
wall R1 and EBD uptake (r=0.782; P<0.001; Figure IIB in the 
data Supplement) and between the R1 and normalized albumin 
area (r=0.83; P<0.001; Figure IIC in the Data Supplement). 
There was also a statistically significant correlation between 
EBD and normalized albumin area (r=0.80; P<0.001; data 
not shown). The correlation between the DE-MRI and his-
tology was not statistically significant when all time points 
after injury were included (r=0.41; P=0.02; Figure IID in the 
Data Supplement). However, the correlation was significant 
Figure 2. Vascular permeability is higher in NOS3-knockout 
(NOS3−/−) mice after aortic endothelial denudation, as measured 
by gadofosveset uptake. Cross-sectional relaxation rate (R1) 
mapping of the abdominal aorta at different time points. First row, 
wild-type (WT) animals and second row, NOS3−/− mice. Asterisks 
indicate aortic lumens; arrows indicate aortic vessel walls. The 
bar graph shows quantification of vessel wall R1 as measured by 
MRI (n=6). NOS3 indicates endothelial nitric oxide synthase.
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(r=0.78; P<0.001; Figure IID in the Data Supplement) after 
the acute phase (7 days), when measurements derived from 
sham-operated animals and at 15 and 30 days post injury were 
included.
Discussion
In this study, we investigated the applicability of the albumin-
binding MR contrast agent, gadofosveset, to noninvasively 
monitor focal changes in vascular permeability and remodel-
ing, after injury, in NOS3-knockout (NOS3−/−) and WT mice 
in vivo. We demonstrate that (1) increased vascular permeabil-
ity, measured in situ using T1 mapping, showed higher vessel 
wall R1 rates in NOS3−/− mice at 15 and 30 days postinjury 
compared with WT animals, and correlated with measures 
of vascular permeability, including EBD and albumin immu-
nohistochemistry. In addition, histological staining, includ-
ing PECAM-1, showed impaired re-endothelialization and 
neovessel formation in NOS3−/− compared with WT animals. 
(2) DE-MRI using an albumin-binding contrast agent, gado-
fosveset, enables in vivo quantification of vascular remodeling 
after injury. NOS3−/− mice showed significantly larger vascular 
remodeling, measured as increased contrast-enhanced area by 
MRI, compared with WT animals 15 and 30 days after injury. 
Ex vivo H&E validated the presence of extensive vascular 
remodeling in NOS3−/− mice compared with WT animals. We 
propose that uptake of gadofosveset into the vessel wall mea-
sured with T1 mapping and DE-MRI could provide surrogate 
markers to assess the healing response of the vessel wall in 
response to vascular injury.
Several experimental murine models of induced vascular 
injury have been described.34–37 Arterial ligation and mechani-
cally induced denudation are among the 2 most common 
procedures. Although the model of arterial ligation provided 
important insights in the biological processes involved in vas-
cular remodeling, it did not allow evaluation of the role of 
the endothelium that was 1 of the primary goals of our study. 
Mechanically induced vascular injury using guide wires 
causes endothelial denudation but it could also tear the elas-
tic lamina. To overcome this complication, non–guide wire 
methods have been developed12,36 that showed similar histo-
logical vessel wall changes to those observed after percuta-
neous interventions, both in animal models37,38 and humans.39 
Particularly, using a non–guide wire surgical procedure, we 
characterized the differences in the vascular response between 
NOS3−/− and WT mice by histology.12
In our study, we found that the highest vascular perme-
ability occurred 7 days after vascular injury, as measured by 
in vivo and ex vivo methods, and was similar between the 2 
strains. However, in vivo measurements of vascular remodel-
ing, as measured by DE-MRI at 7 days overestimated the ves-
sel wall area compared with that measured by H&E staining. 
Figure 3. Vessel wall gadofosveset enhancement 
is higher in NOS3-knockout (NOS3−/−) mice after 
aortic endothelial denudation. First and third col-
umns, wild-type (WT) and NOS3−/− cross-sectional 
delayed-enhancement MR images (DE-MRI) of the 
abdominal aorta. Second and fourth columns, cor-
responding WT and NOS3−/− DE-MRI fused with 
magnetic resonance angiography images. NOS3−/− 
mice after vascular injury show persistent gado-
fosveset enhancement, whereas WT animals show 
decreased gadofosveset enhancement over time. 
Bar graph shows quantification of the contrast-
enhanced vessel wall area as measured by MRI 
(n=6). Scale bar corresponds to 0.3 mm. NOS3 
indicates endothelial nitric oxide synthase.
6  Lavin et al  MRI of Vascular Permeability and Remodeling 
This might be because of the lack of the endothelial barrier, 
which allows for unobstructed leakage of molecules in the 
blood (eg, albumin, gadofosveset) into the vessel wall, lead-
ing to high permeability that is not necessarily accompanied 
by the presence of vascular remodeling. This data suggest 
that in an acute phase of vascular injury, changes in perme-
ability occur first and precede formation of vascular remod-
eling. Whether increased permeability will be followed by 
Figure 5. Re-endothelization is impaired in NOS3-knockout (NOS3−/−) after endothelial denudation. A, PECAM-1 immunohistochemistry 
(n=3) shows impaired endothelial cell regeneration in NOS3−/− animals when compared with wild-type (WT) mice after endothelial denuda-
tion (black, PECAM-1; pink, nuclei). B, Histological identification of neovessels (positive for PECAM-1) in NOS3−/− mice at 15 and 30 days 
after endothelial denudation. Examples of endothelial disruption (C; arrow) and denudation (D; arrow) in NOS3−/− 30 days after injury using 
PECAM-1 immunochemistry. E, WT mice show endothelial cell regeneration. F, Hematoxylin and eosin stain (H&E; n=4) shows larger 
areas with vascular remodeling and an increased vessel wall area in NOS3−/− mice when compared with WT animals. Scale bars corre-
spond to 0.3 mm. NOS3 indicates endothelial nitric oxide synthase.
Figure 4. Vascular permeability is higher in NOS3-knockout (NOS3−/−) mice after endothelial denudation. A, In situ Evans blue dye (EBD; 
n=4) shows a persistent leakage of EBD into the vessel wall in NOS3−/− mice after vascular injury, whereas wild-type (WT) mice show 
normalization over time. B, Serum albumin immunohistochemistry (n=4) in WT and NOS3−/− mice shows increased albumin leakage into 
the vessel wall in NOS3−/− when compared with WT mice after injury. Scale bar corresponds to 0.3 mm. NOS3 indicates endothelial nitric 
oxide synthase.
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remodeling may partly depend on the subsequent re-endothe-
lialization of the vessel wall. However, after the acute phase 
of endothelial injury (7 days), DE-MRI was in good agree-
ment with vascular remodeling quantified by histology. For 
this reason, the differences in the long-term vascular response 
between NOS3−/− and WT mice could be deciphered. NOS3−/− 
mice showed persistently higher R1 values and vessel wall 
enhancement on DE-MRI at 15 and 30 days after injury, 
which correlated with histological measures of both vascu-
lar permeability and remodeling, respectively. Conversely, R1 
and DE-MRI values decreased close to baseline levels in WT 
animals. It is unclear if gadofosveset interacts nonspecifically 
with matrix proteins or other components of the vessel wall, 
but in our previous publication, we have shown that gadofos-
veset accumulates within the vessel wall without showing 
preferential localization in specific plaque components using 
x-ray film gadolinium spectra.33 In this study, we propose that 
longitudinal measurements of both vascular permeability and 
remodeling in a single MRI examination provide a more com-
prehensive understanding of the focal responses of the vessel 
wall to injury.
Our histological analysis using PECAM-1 immunohisto-
chemistry showed impaired re-endothelialization and neoves-
sel formation only in NOS3−/− mice 15 and 30 days after 
injury. Ultrastructural description using TEM showed some 
evidences of morphological changes of the endothelium in 
both NOS3−/− and WT animals, including large cytoplasmic 
vacuoles, altered endothelial cells shape, microvilli, and par-
tial fragmentation of elastin fibers. Similar morphological 
changes have been previously reported in specimens from 
both animal models40 and humans41 with different cardiovas-
cular risk factors. Nevertheless, a comprehensive morpho-
metric and quantitative analysis of the TEM images would 
be required to elucidate the mechanism responsible for the 
differences in permeability observed between the 2 strains. 
Impaired re-endothelialization and increased neovasculariza-
tion in NOS3−/− mice resulted in increased vascular permeabil-
ity as measured by EBD and vascular remodeling measured 
by H&E. These results are in good agreement with previous 
histological studies that showed the importance of NOS3-
derived nitric oxide in a large number of vascular diseases.15,42
In our study, in vivo measurements of R1 are complimentary 
to that of EBD. Although the 2 techniques rely on the same 
biological process, the units of each one are not identical and 
thus cannot be directly compared. The patterns of the changes, 
however, between animals and time points are similar between 
these 2 techniques (see Figures 2 and 4A). The measurements 
of DE-MRI area and H&E expressed in mm2 might be more 
suitable for direct comparison (Figures 3 and 5F). However, in 
our study, the DE-MRI areas measured on consecutive slices 
along the aorta and were added for each animal to express the 
extent of vessel wall remodeling occurring in each time point. 
Conversely, histology was not performed continuously along 
the entire length of the vessel but rather in small vascular seg-
ments of the aorta. For this reason, the DE-MRI area is always 
larger compared with the reported histological area.
Different pathways exist to transport molecules across the 
endothelium. The glycocalyx together with vesicular transport 
and normal breaks in the tight junctions collectively regulate 
albumin and other solute flux through intact endothelium into 
the vessel wall of healthy animals.43 Albumin transport through 
these pathways may represent intact endothelium, and could 
justify the low vessel wall enhancement observed in the 
DE-MRI and R1 measurements of sham-operated animals and 
could also partially contribute to the signal observed in injured 
vessels. Importantly, our study also showed that in addition to 
these transport pathways, disruption of the structural integrity of 
the endothelium together with neovascularization after vascular 
injury, particularly in NOS3−/− animals, significantly increase 
vascular permeability and albumin leakage into the vessel wall. 
These vascular changes could be noninvasively quantified by 
gadofosveset MRI and are corroborated by histology.
Limitations
Although structural changes of the endothelium may be 
accompanied by functional alterations of the vasodilatory 
responses, genetic deletion of the NOS3 gene and lack of pro-
tein expression makes the vessel wall inherently irresponsive 
to acetylcholine stimulation. To this end, we did not assess 
endothelial function in our study. Another limitation of our 
study is that in the acute phase of vascular injury DE-MRI 
overestimated the area of vascular remodeling compared with 
histology. However, after the acute phase of injury, both vas-
cular permeability and remodeling measured in vivo corre-
lated with the corresponding histological measurements.
Conclusions
Measuring vascular permeability and remodeling by gado-
fosveset-enhanced MRI may provide surrogate markers for 
the noninvasive direct evaluation of the healing response of 
the vessel wall after vascular injury. It could also be used for 
evaluating the efficacy of treatments aimed at promoting re-
endothelialization and attenuating vascular remodeling.
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CLINICAL PERSPECTIVE
Despite the beneficial effects of percutaneous coronary intervention and stent implantation, these procedures may damage 
the vessel wall, particularly the endothelial layer, leading to increased vascular permeability and remodeling. Re-endothelial-
ization of the vessel wall with functionally and structurally intact endothelial cells is crucial for minimizing vascular perme-
ability and remodeling and maintaining the long-term patency of the treated vessel. Therefore, longitudinal measurements 
of both vascular permeability and remodeling in a single MRI examination provide a more comprehensive understanding 
of the focal responses of the vessel wall to injury. We propose that uptake of gadofosveset, a clinically approved albumin-
binding contrast agent, into the vessel wall using T1 mapping and DE-MRI protocols provides measurements of vascular 
permeability and remodeling. These biological processes could be used as surrogate markers to assess the healing response 
of the vessel wall in response to vascular injury.
